Prof. Dr. Dr. Anette Melk is a Professor of Pediatrics and Interdisciplinary Experimental Transplantation Medicine at Hannover Medical School. Dr. Melk’s work on pathways leading to impaired regeneration in the pathogenesis of kidney and cardiovascular diseases includes basic findings and concepts from cell and animal models to clinical applications. She has pioneered the idea that cellular senescence is crucial for the insufficient regenerative capacity of donor organs and an important target in therapeutic approaches.
Dr. Melk’s clinical research projects aim to further decipher factors leading to cardiovascular and renal comorbidity in transplant recipients. She initiated the largest longitudinal clinical study assessing cardiovascular health in children and adults after solid organ and stem cell transplantation (4C-T, cardiovascular comorbidity in children with chronic disease and transplantation). Dr. Melk’s holistic view on optimization of patient and graft survival lead her build the first German research consortium that deals with sex- and gender-related differences in kidney transplantation.
She is speaker of the center for gender-sensitive medicine at MHH, advocating a sex and gender-sensitive medicine in research, clinic, patient and science communication as well as teaching. She is the chair of the DFG-funded Young Academy – PRACTIS (PRogram of hAnnover medical school for Clinician scienTISts). Dr. Melk received her MD at the University of Giessen (Germany) and her PhD from University of Alberta (Canada). She trained as a Pediatric Nephrologist at the University of Heidelberg Children’s Hospital. Dr. Melk serves on several national and international boards. She has received numerous awards, one of which is the prestigious Rudolf-Pichlmayr-Preis of the German Transplantation Society.